E-LIB Suche - Ergebnisse für: Kamimaki, Chisato - Sprache DE

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

Adverse events induced by durvalumab and tremelimumab combi..:

Matsumoto, Hiromi ; Somekawa, Kohei ; Horita, Nobuyuki...
Therapeutic Advances in Medical Oncology. 15 (2023) - p. , 2023

Link: https://doi.org/10.1177/..

2

Whole-Genome Sequencing Predicting Phenotypic Antitubercula..:

Tagami, Yoichi ; Horita, Nobuyuki ; Kaneko, Megumi...
The Journal of Infectious Diseases. 229 (2023) 5 - p. 1481-1492 , 2023

Link: https://doi.org/10.1093/..

3

Regional differences in epidermal growth factor receptor-ty..:

Matsumoto, Hiromi ; Kobayashi, Nobuaki ; Shinoda, Satoru...
Scientific Reports. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

4

A functionally improved case of obstructive impairment caus..:

Kamimaki, Chisato ; Yamamoto, Masaki ; Sawazumi, Tomoe..
Breathe. 17 (2021) 2 - p. 200288 , 2021

Link: https://doi.org/10.1183/..

5

Pembrolizumab monotherapy versus pembrolizumab plus chemoth..:

Matsumoto, Hiromi ; Kobayashi, Nobuaki ; Somekawa, Kohei...
Thoracic Cancer. 13 (2021) 2 - p. 228-235 , 2021

Link: https://doi.org/10.1111/..

6

T‐cell response to phytohemagglutinin in the interferon‐γ r..:

Kamimaki, Chisato ; Kobayashi, Nobuaki ; Hirata, Momo...
Thoracic Cancer. 12 (2021) 11 - p. 1726-1734 , 2021

Link: https://doi.org/10.1111/..

7

Resistance mechanisms of epidermal growth factor receptor t..:

Kobayashi, Nobuaki ; Katakura, Seigo ; Kamimaki, Chisato...
Thoracic Cancer. 12 (2021) 7 - p. 1096-1105 , 2021

Link: https://doi.org/10.1111/..

8

Identification of a novel biomarker based on lymphocyte cou..:

Katakura, Seigo ; Kobayashi, Nobuaki ; Hashimoto, Hisashi...
Tuberculosis. 125 (2020) - p. 101992 , 2020

Link: https://doi.org/10.1016/..

9

Afatinib + bevacizumab combination therapy in EGFR‐mutant N..:

Kobayashi, Nobuaki ; Hashimoto, Hisashi ; Kamimaki, Chisato...
Thoracic Cancer. 11 (2020) 8 - p. 2125-2129 , 2020

Link: https://doi.org/10.1111/..

10

MicroRNA‐200b is a potential biomarker of the expression of..:

Katakura, Seigo ; Kobayashi, Nobuaki ; Hashimoto, Hisashi...
Thoracic Cancer. 11 (2020) 10 - p. 2975-2982 , 2020

Link: https://doi.org/10.1111/..

11

Class A CpG oligodeoxynucleotide inhibits IFN‐γ‐induced sig..:

Teranishi, Shuhei ; Kobayashi, Nobuaki ; Katakura, Seigo...
Thoracic Cancer. 11 (2020) 4 - p. 983-992 , 2020

Link: https://doi.org/10.1111/..

12

Adverse events induced by durvalumab and tremelimumab combi..:

Matsumoto, Hiromi ; Somekawa, Kohei ; Horita, Nobuyuki...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501063/. , 2023

Link: http://www.ncbi.nlm.nih...

13

A functionally improved case of obstructive impairment caus..:

Kamimaki, Chisato ; Yamamoto, Masaki ; Sawazumi, Tomoe..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291943/. , 2021

Link: http://www.ncbi.nlm.nih...

14

Pembrolizumab monotherapy versus pembrolizumab plus chemoth..:

Matsumoto, Hiromi ; Kobayashi, Nobuaki ; Somekawa, Kohei...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758435/. , 2021

Link: http://www.ncbi.nlm.nih...

15

MicroRNA‐200b is a potential biomarker of the expression of..:

Katakura, Seigo ; Kobayashi, Nobuaki ; Hashimoto, Hisashi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529545/. , 2020

Link: http://www.ncbi.nlm.nih...

1-15